Fibromuscular Dysplasia: Causes, Symptoms, and Treatment

Fibromuscular dysplasia (FMD) is a non-inflammatory disease of the artery walls that causes abnormal cell growth in one or more layers of the vessel, leading to narrowing, aneurysm, or tearing of arteries. It predominantly affects women, with roughly nine out of ten diagnosed patients being female, and most commonly targets the renal and carotid arteries.¹ Because it can show up in virtually any arterial bed and mimic other vascular conditions, FMD is often misdiagnosed or caught late, sometimes only after a complication like stroke or arterial dissection has already occurred.

What FMD Actually Does to Arteries

In a healthy artery, the wall has three layers: an inner lining, a muscular middle layer, and an outer layer of connective tissue. FMD disrupts normal growth in one or more of these layers, and the specific layer affected determines the subtype. The most common form involves the middle (medial) layer, producing a characteristic “string of beads” pattern visible on imaging, where alternating bulges and narrowings give the artery a beaded look.² A less common pattern, called focal FMD, appears as a single tight narrowing rather than a beaded chain. Both forms can restrict blood flow, weaken the artery wall enough to form an aneurysm, or set the stage for a dissection, in which the inner lining tears and blood tracks between the layers.

From U.S. registry data, roughly one in four FMD patients has an arterial dissection by the time of diagnosis, and about one in five has an aneurysm. The carotid, renal, and intracranial arteries are the most frequent sites for aneurysm, while dissection most often strikes the carotid, vertebral, renal, and coronary arteries.³ Those complications are what make FMD dangerous rather than merely unusual; the narrowing alone may be asymptomatic, but a sudden dissection or a ruptured aneurysm is an emergency.

Who Gets FMD

The demographics of FMD are striking. Analysis of over 4,500 diagnosed cases in the United States found that 85% of patients were female and about 81% were white. Prevalence was roughly four and a half times higher in women than in men.⁴ The average age at diagnosis in the first large U.S. registry cohort was about 52 years, though cases have been identified in patients as young as 5 and as old as 83.¹

The heavy female skew has led researchers to suspect hormonal factors, but the picture is more complicated than “estrogen causes FMD.” High-estrogen states like pregnancy or oral contraceptive use do not appear to increase the risk of developing FMD or its complications.⁵ That finding is an important corrective to a misconception that still circulates in older clinical literature. The female predominance is real, but the mechanism behind it remains unclear.

Not all populations look the same. A Chinese cohort of patients with renal FMD was diagnosed at a much younger average age of about 27 years, and the sex ratio was considerably less skewed, with about 56% women. Among children in that cohort, boys actually slightly outnumbered girls.⁶ A pediatric study from the United States found a similarly higher proportion of boys (48% compared to 9% in the adult registry), along with greater racial and ethnic diversity.⁷ This suggests that the classic profile of FMD, a middle-aged white woman, reflects referral and screening patterns as much as biology. The disease genuinely occurs in men, children, and diverse racial groups, and may be underdiagnosed in those populations.

Causes and Genetic Risk

FMD has no single known cause. Smoking is the best-established environmental risk factor and appears to modify disease severity; active smoking has been linked to earlier onset of associated hypertension and to a higher rate of aneurysms and claudication symptoms in FMD patients.⁵

On the genetic side, FMD follows a complex inheritance pattern, meaning it is not caused by a single gene but instead involves contributions from multiple common genetic variants. The first gene firmly linked to FMD was PHACTR1, which encodes a protein involved in regulating actin (part of the cell’s structural skeleton). A genome-wide study of over 1,100 cases and nearly 3,900 controls found that a variant near PHACTR1 increased FMD risk by about 39%.⁸ A larger follow-up study replicated that association and identified three additional risk loci: LRP1, LIMA1, and ATP2B1.⁹

These genes are each individually modest in their effect, raising risk by roughly 30–44%. But a useful insight from this genetic work is that several of these same loci overlap with risk genes for other cardiovascular diseases, including coronary artery disease and migraine. That shared genetic architecture helps explain why FMD patients often present with a cluster of vascular problems rather than isolated artery narrowing.

Symptoms When the Kidneys Are Involved

Renal artery FMD is the most common presentation of the disease, and its primary symptom is high blood pressure, especially when it appears in someone young or is resistant to standard medications. The mechanism seems intuitive: a narrowed renal artery should reduce blood flow to the kidney, triggering the body’s blood-pressure-raising hormones. But the reality is more nuanced than that textbook picture suggests.

Research comparing kidney blood flow and filtration in FMD patients with healthy controls found that renal blood flow and kidney filtration were actually comparable between the two groups. Systemic levels of renin, the hormone that drives blood pressure up, were somewhat higher in FMD patients, yet the kidneys themselves were not secreting excess renin. Even in patients with FMD on just one side, the affected kidney performed no differently than the unaffected one in terms of blood flow, filtration, or hormone output.¹⁰ That means the connection between renal FMD and high blood pressure is less straightforward than was long assumed, and it has practical implications: not every patient with renal FMD and hypertension will see their blood pressure resolve after fixing the stenosis.

Symptoms When the Head and Neck Arteries Are Involved

Cerebrovascular FMD most commonly affects the carotid and vertebral arteries in the neck. The symptoms are quite different from renal FMD and can be easy to dismiss. Headaches and pulsatile tinnitus, a rhythmic whooshing or heartbeat sound in one ear, are the most frequent complaints.¹¹ In the U.S. registry, about 37% of FMD patients reported pulsatile tinnitus.¹²

Patients with pulsatile tinnitus were more likely to also have headache, dizziness, and an audible bruit (a swishing sound the doctor can hear with a stethoscope over the neck). Headache was present in about 83% of the tinnitus group compared to 63% without tinnitus, and dizziness was roughly twice as common.¹² These symptoms cluster together because they all reflect turbulent blood flow through irregular arteries supplying the brain.

The more serious manifestations of cerebrovascular FMD include transient ischemic attack, stroke, and subarachnoid hemorrhage from a ruptured brain aneurysm. These are less common than headaches and tinnitus but represent the chief danger. Spontaneous carotid or vertebral artery dissection, where the artery wall tears without any traumatic cause, is also a well-known complication and may be the first sign of FMD in some patients.

FMD Beyond the Kidneys and Brain

Although the renal and head-and-neck arteries get the most attention, FMD can appear in almost any arterial bed. A study of iliac artery FMD, for example, found that more than half of those patients were diagnosed incidentally during imaging performed for unrelated reasons. The patients who did have symptoms mostly reported claudication, or pain and cramping in the legs during activity. Nearly all patients with iliac FMD also had involvement of other arteries, most commonly renal.¹³ The lesson is that when FMD turns up in one vascular bed, it is worth looking elsewhere too.

The Link With Spontaneous Coronary Artery Dissection

One of the most clinically significant associations is between FMD and spontaneous coronary artery dissection (SCAD), a tear in the coronary artery wall that can cause a heart attack, typically in younger women with no conventional cardiac risk factors. Screening studies of SCAD survivors have found FMD in up to 45% of them, suggesting that SCAD may be the most common way FMD presents in the coronary arteries.¹⁴ The classic beaded appearance is rare in the coronary vessels; instead, the disease manifests as dissection, focal narrowing, or abnormal arterial tortuosity.

FMD and SCAD share demographic overlap (young to middle-aged women), shared genetic risk loci, and a high rate of extracoronary vascular abnormalities in SCAD patients, including aneurysms and dissections elsewhere in the body.¹⁵ If you have been diagnosed with SCAD, being screened for FMD in other arteries is now standard practice in many centers, and the reverse is also true.

How FMD Is Diagnosed

Diagnosis usually starts with imaging. The two most accessible options are Doppler ultrasound and CT angiography (CTA). There is an emerging argument that Doppler ultrasound, while often considered the less glamorous option, may actually outperform CTA for detecting significant renal artery narrowing from FMD. A recent comparative analysis found that Doppler ultrasound had substantially higher sensitivity for severe stenoses than CTA, particularly in smaller branch arteries, where CTA detected only about a fifth of the lesions that ultrasound caught. Both modalities had very high specificity, meaning they rarely called a normal artery abnormal.¹⁶

When non-invasive imaging is inconclusive, catheter-based angiography remains the gold standard. It allows the doctor to visualize the artery in real time and to measure the pressure drop across a narrowed segment. A pressure ratio below 0.90 is generally considered significant, though that threshold is borrowed from atherosclerotic disease research and has not been specifically validated for FMD.¹⁷ Visual estimates of how severe a narrowing looks on angiography correlate poorly with actual pressure measurements, which means appearances can be deceiving and functional testing matters.¹⁸

Medical Management

There is no pill that reverses FMD itself. Medical therapy focuses on managing its consequences, chiefly high blood pressure and the risk of blood clots or arterial events. In the U.S. registry, about 73% of FMD patients were on an antiplatelet drug like aspirin. Use patterns varied by which arteries were affected: patients with cerebrovascular FMD were more likely to be on antiplatelet agents, while those with isolated renal FMD received more blood-pressure-lowering drugs.¹⁹ This makes intuitive sense: the biggest risk from cerebrovascular FMD is stroke from a clot, while renal FMD mainly threatens through high blood pressure.

For hypertension associated with renal FMD, ACE inhibitors and angiotensin receptor blockers are commonly used, though care is needed because these drugs can impair kidney function when flow through the renal artery is severely restricted. Patients often end up on multiple blood-pressure medications, and the number of drugs needed tends to increase with age and with a history of prior interventions.

Balloon Angioplasty for Renal FMD

The mainstay of interventional treatment for renal artery FMD is percutaneous transluminal renal angioplasty (PTRA), which is balloon angioplasty without a stent. A catheter is threaded to the narrowed segment, a balloon is inflated to open it up, and the balloon is then removed. Unlike in atherosclerotic disease, a stent is usually not placed because FMD lesions tend to respond well to stretching alone.

Outcomes are generally encouraging. A Chinese cohort study reported a technical success rate above 93%, with significant drops in blood pressure and improvements in kidney-function markers after the procedure.²⁰ A European prospective study found that hypertension was cured or improved in 93% of patients immediately after angioplasty, though that figure dropped to about 74% at one year, with a restenosis rate of 23% at twelve months.²¹ Long-term data show that about 73% of patients maintain a blood-pressure benefit at five years. Stent placement was required in roughly 13% of cases for technical failure or a dissection caused by the procedure itself.²²

These numbers highlight an important point for patients: angioplasty is not a guaranteed cure for high blood pressure. Younger patients, those diagnosed earlier, and those with fewer years of hypertension tend to have the best results. If high blood pressure has been present for many years, the kidneys and blood vessels may have undergone changes that persist even after the narrowing is opened.

When Surgery Is Needed

Open surgical repair is reserved for situations where angioplasty fails, where the anatomy is too complex for a catheter approach, or where branch arteries deep within the kidney are involved. A surgical series found that about a third of branch-artery repairs required an “ex vivo” technique, in which the kidney is temporarily removed from the body, the artery is repaired on a workbench under magnification, and the kidney is then reimplanted. Among patients treated surgically, about a third were cured of hypertension, 57% were improved, and 10% saw no benefit. There were no deaths, but 7% of arterial grafts failed within 30 days.²³

Surgery is not common anymore; the vast majority of renal FMD is managed with angioplasty. But for branch-vessel disease or recurrent restenosis after repeated balloon procedures, surgery remains a valuable option, particularly in specialized centers with vascular surgery expertise.

FMD in Children

Pediatric FMD looks different from the adult version in several ways. As noted above, the sex ratio is much more balanced. Children also present differently: in one pediatric cohort, none reported neck pain or pulsatile tinnitus, symptoms that are common in adults. Aneurysms were rare, and stroke was absent entirely from the pediatric group, compared with over half of adult registry patients having cerebrovascular involvement.⁷ Chinese pediatric data show a similar pattern: most children had the focal subtype of FMD rather than the multifocal beaded pattern typical in adults, and boys slightly outnumbered girls.⁶

The practical implication is that a child with unexplained high blood pressure, especially one who is otherwise healthy, should be evaluated for renal artery FMD. The disease may look different on imaging than in adults, making it harder to spot with standard screening approaches calibrated for multifocal disease.

Living With FMD and Long-Term Monitoring

FMD is a lifelong condition. Even after successful treatment of a narrowed artery, new lesions can develop in the same or different vascular territories. Most experts recommend periodic imaging surveillance. The specific schedule varies, but a common approach involves repeat ultrasound or CTA every one to two years, particularly in the first few years after diagnosis or intervention, to watch for restenosis or new disease.

Patients are generally advised to avoid smoking, since it worsens outcomes and accelerates vascular damage. Blood-pressure control matters even after angioplasty, and many patients stay on at least one antihypertensive medication long term. For those with cerebrovascular FMD, low-dose aspirin is often continued indefinitely to reduce the risk of stroke, though randomized trial data specific to FMD are scarce, and these recommendations are largely extrapolated from general vascular guidelines.

One underappreciated aspect of living with FMD is the diagnostic odyssey many patients endure. Because the disease is uncommon and its symptoms overlap with far more frequent conditions like essential hypertension, migraine, or benign positional vertigo, years can pass between symptom onset and correct diagnosis. Patient advocacy organizations have pushed for greater awareness among primary care providers, and the expansion of vascular screening in high-risk groups, particularly women with early-onset or treatment-resistant hypertension, has helped shorten that gap for some.

Treating Pulsatile Tinnitus in Cerebrovascular FMD

For most patients with FMD-related pulsatile tinnitus, the symptom is mild, more annoying than disabling. But a small subset experiences tinnitus severe enough to interfere with sleep, concentration, and daily life. In rare cases, stenting of the affected carotid artery has been used to restore normal flow dynamics and relieve the whooshing. A therapeutic review found that self-expanding carotid stents can reduce turbulent flow through the irregular segment and alleviate symptoms, though the evidence base is limited to case reports and small series rather than randomized trials.²⁴ Stenting for tinnitus alone remains the exception, not the rule, and is typically considered only when symptoms are genuinely debilitating and unresponsive to conservative measures.